- Home
- Equipment
- united kingdom
- breast cancer with adjacent normal breast
Refine by
Breast Cancer With Adjacent Normal Breast Equipment Supplied In United Kingdom
18 equipment items found
Manufactured by:AMS Biotechnology (Europe) Ltd. based inAbingdon, UNITED KINGDOM
Breast cancer with adjacent normal breast tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, repalcing BR245. Breast carcinoma with adjacent normal breast tissue ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
The Mimetix fibres are labelled with Rhodamine 6G. The thickness of Mimetix scaffold allows for having a 3D environment while maintaining a certain translucence, thus allowing for easy and robust imaging. This study has investigated the localisation depth of MCF7 breast cancer cells in the Mimetix scaffold after 4 days of culture (nuclei stained with TO-PRO-3, blue). The video below shows a ...
Manufactured by:Menssana Research Inc. based inEdgewater, NEW JERSEY (USA)
It takes 300 screening mammograms to discover one woman with breast cancer. A breath test might improve this very low yield. Researchers have known for many years that women with breast cancer have abnormal volatile organic compounds (VOCs) in their breath. Clinical studies at Menssana Research have shown that these breath VOCs can accurately identify women with early stage breast cancer or an ...
Manufactured by:Care Wise Medical Products Corporation based inHENFIELD, UNITED KINGDOM
C-Trak Apollo wireless and wired gamma probe for radio guided surgery.Superior directionality and complete flexibility. The C-Trak Apollo gamma probe allows for the detection of radiation during sentinel node biopsies, parathyroid and tumour localisation. The C-Trak Apollo’s distinctive feature is our superior sensitivity and directionality, but now we also offer wired and wireless ...
Manufactured by:Sequana Medical NV based inSint-Denijs Westrem, BELGIUM
Ascites is also a common complication of certain late-stage cancers due to fluid build-up in the peritoneal cavity from a number of causes including draining of the lymph system. While life expectancy for many cancer patients with malignant ascites is short (less than 3 months), ovarian and breast cancer patients often have longer life expectancies. In 2018, the incidence in the U.S. and EU5 is ...
by:Exact Sciences UK, Ltd. based inLondon, UNITED KINGDOM
Every cancer is unique and affects each diagnosed person differently based on the individual biology of his or her disease. To address this diversity and make cancer care smarter at every stage, our Oncotype DX genomic tests and services portfolio delivers clinically relevant genomic intelligence that reveals the individual biology of a patient's ...
Manufactured by:Yourgene Health based inManchester, UNITED KINGDOM
Elucigene DPYD assay is a simple genotyping test that can identify patients with DPD deficiency allowing an alternative treatment to be offered. 5-fluorouracil (5-FU) is a chemotherapy agent used to treat a range of cancers including colorectal, head and neck, breast, pancreatic and stomach cancer. 5-FU is metabolized by the dihydropyrimidine dehydrogenase enzyme (DPD) which is encoded by the ...
Manufactured by:Biosceptre International Limited based inCambridge, UNITED KINGDOM
nfP2X7 is a tumour-specific form of the P2X7 ligand-gated ion channel, consisting of three identical protein subunits. When exposed to high concentrations of extracellular adenosine triphosphate (ATP), P2X7 forms a channel, driving a range of diverse physiological functions including proliferation and immune cell functions. Under prolonged stimulation, P2X7 can form a membrane pore that’s ...
Manufactured by:Micrima Limited based inBristol, UNITED KINGDOM
Micrima are aiming to open up breast screening to all women. With breast cancer being the most common cancer in women of all ages globally, we believe that all women should be able to have breast screening. The current option for screening is mammography, which has limitations in women with dense breasts. MARIA® scans, with non-ionising radiation, increases the frequency women can be scanned ...
Manufactured by:Care Wise Medical Products Corporation based inHENFIELD, UNITED KINGDOM
This device has now been superseded by the C-Trak Apollo gamma probe system and is no longer available. Gamma Probe for Sentinel Node Biopsy: Accurate and precise gamma probe for detection of radiation for use during sentinel node biopsies, allowing the detection of radiation with smaller incisions and faster patient ...
Manufactured by:Immunodiagnostic Systems Holdings PLC based inBoldon Colliery, UNITED KINGDOM
LISA-TRACKER anti-Trastuzumab is an enzyme linked immunoassay (ELISA) for the quantitative determination of anti-Trastuzumab antibodies in human serum ...
Manufactured by:TC BioPharm based inHolytown, UNITED KINGDOM
TCB006 is an allogeneic CAR-T product targeting B7-H4 for the treatment of cancers arising from solid tumors. B7-H4 antigen is overexpressed in breast cancers, especially triple negative breast cancer, and ovarian cancers, both diseases with acute clinical needs. There are 270,000 new cases of breast cancer and 23,000 new cases of ovarian cancer per year in the US. It is also implicated ...
Manufactured by:EnteroBiotix Ltd based inGlasgow, UNITED KINGDOM
Immuno-oncology exploits the mechanisms of the body’s own natural immune response, either by stimulating or suppressing it, to fight ...
Manufactured by:Avelas Biosciences based inLa Jolla, CALIFORNIA (USA)
Pegloprastide (AVB-620) is based on the science of activatable cell-penetrating peptides and is designed to deliver a fluorescent marker specifically to cancer cells to enable surgeons to identify cancerous tissue in real-time and thus, avoid repeat surgeries and improve patient outcomes. Pegloprastide is the only fluorescence-based clinical cancer detection product that uses the ratio of two ...
Manufactured by:Scancell based inOxford, UNITED KINGDOM
Modi-1 is the first vaccine based on Scancell’s Moditope® platform. The vaccine is composed of a combination of three peptides from two target antigens that are commonly modified in cancer cells. The first is the cytoskeletal protein, vimentin, which is preferentially digested during autophagy. All mesenchymal tumours such as endometrial, renal, sarcomas, lymphomas and lung tumours ...
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Recombinant monoclonal antibody to ENG. It is a human monoclonal antibody that can be potentially used in the treatment of Hepatocellular Carcinoma, Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor, Epithelioid Trophoblastic Tumor, Adult Solid Tumor, Advanced Soft Tissue Sarcoma, Metastatic Breast Cancer, Solid Tumors, Lung Cancer, Hepatoma, Liver ...
Manufactured by:Scancell based inOxford, UNITED KINGDOM
The Modi-2 vaccine exploits a second post-translational modification, stimulating the production of CD4 T cells using tumour-associated peptide epitopes in which the lysine residues are converted to homocitrulline. This change occurs via a process known as carbamylation, leading to a change in molecular charge which, in turn, alters antigenic properties and can result in the generation of unique ...
by:Thermo Fisher Scientific, LIMS & Laboratory Software based inPhiladelphia, PENNSYLVANIA (USA)
Create physiologically relevant cell culture models. Gibco Human Plasma-like Medium (HPLM) is a new formulation designed to resemble the natural cellular environment found in the body, mimicking the metabolic profile of human plasma. The widely used classic synthetic cell culture media, including MEM, DMEM, RPMI 1640, and DMEM/F-12 contain glucose, amino acids, vitamins, and salts at ...